(Q74045638)
Statements
CCK-B/Gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides (English)
M Bläker
Y Ren
L Seshadri
E W McBride
M Beinborn